Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Hotcoin Research | Fusaka Upgrade Approaching: Analysis and Outlook on Ethereum Long and Short Positions
Hotcoin Research | Fusaka Upgrade Approaching: Analysis and Outlook on Ethereum Long and Short Positions

This article will review Ethereum's recent performance, provide an in-depth analysis of the current bullish and bearish factors facing Ethereum, and look ahead to its prospects and trends for the end of this year, next year, and the medium to long term. The aim is to help ordinary investors clarify uncertainties, grasp trends, and provide some reference to support more rational decision-making during key turning points.

深潮·2025/11/23 19:21
Crypto Market Surges as Bitcoin Rebounds and Privacy Coins Shine
Crypto Market Surges as Bitcoin Rebounds and Privacy Coins Shine

In Brief Bitcoin rebounded over the weekend, testing the $86,000 mark. Privacy-focused altcoins Monero and Zcash showed notable gains. Total market value surged, crossing the $3 trillion threshold again.

Cointurk·2025/11/23 18:45
Crypto Markets Rebound as Traders Signal Seller Fatigue
Crypto Markets Rebound as Traders Signal Seller Fatigue

In Brief Crypto markets rebounded amid significant liquidations and oversold RSI signals. Weekend trading conditions with thin liquidity influenced rapid price shifts. The rebound's sustainability remains uncertain, prompting scrutinous investor attention.

Cointurk·2025/11/23 18:45
XRP Down 35 % As ETF Fail To Impress
XRP Down 35 % As ETF Fail To Impress

Cointribune·2025/11/23 18:39
After a 1460% surge, re-examining the value foundation of ZEC
After a 1460% surge, re-examining the value foundation of ZEC

Narratives and sentiment can create myths, but fundamentals determine how far those myths can go.

Chaincatcher·2025/11/23 16:42
Flash
20:57
US Dollar Index Falls 0.09% on 16th
The US Dollar Index fell 0.09% on the 16th, closing at 99.540 in the foreign exchange market.
20:48
According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a tiered royalty structure.
The document further clarifies the conditions and specific terms that trigger payment. Milestone payments will be distributed in phases based on the progress of R&D in the collaborative project, regulatory approvals, and commercialization outcomes at different stages. Tiered royalties mean that as product sales reach different thresholds, the rates will be adjusted accordingly, providing both parties with a more flexible revenue-sharing mechanism. This financial arrangement highlights both parties' confidence in the project's prospects and reflects the risk-sharing and profit-sharing models commonly seen in the biopharmaceutical industry. Although the details of the agreement have not been fully disclosed, the total potential revenue of up to $320 million undoubtedly injects strong financial momentum into the subsequent development of the project.
20:48
According to a filing submitted to the U.S. Securities and Exchange Commission, biotechnology company Arvinas Holding Company LLC, pharmaceutical giant Pfizer, and Rigel Pharmaceuticals obtained approval under the Hart–Scott–Rodino Antitrust Improvements Act on June 11, 2026.
This key development has removed regulatory obstacles for all parties to advance the previously announced licensing agreement. The conclusion of this agreement marks a new substantive phase in the related cooperation. Passing the HSR antitrust review is a crucial step in strategic collaborations involving intellectual property and market access. This usually means that regulatory authorities have determined the transaction will not materially harm competition in the relevant market. With this regulatory threshold crossed, all parties are expected to accelerate implementation of the detailed terms of the licensing agreement, boosting progress in related R&D or commercialization projects. This dynamic is being closely watched by industry observers.
News